Here is Why Novo Nordisk (NVO) is One of the Best Growth Stocks to Buy for the Next Decade

Novo Nordisk (NYSE: NVO) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Novo Nordisk (NYSE:NVO) is one of the best growth stocks to buy for the next decade. On April 2, Novo Nordisk announced results from the ORION study, which is a population-adjusted indirect treatment comparison/ITC evaluating the efficacy and safety of oral semaglutide 25 mg (Wegovy pill) against orforglipron 36 mg.

Data derived from the OASIS 4 and ATTAIN-1 clinical trials indicate that oral semaglutide 25 mg was associated with greater mean weight loss. The comparison also revealed that orforglipron 36 mg carried roughly 14x higher odds of treatment discontinuation due to gastrointestinal adverse events compared to the semaglutide tablet. The study further highlighted differences in patient tolerability, noting that orforglipron was associated with ~4x higher odds of stopping medication for any adverse event.

While the ORION analysis adjusted for baseline characteristics such as body weight and sex, researchers noted that trial protocol differences and low event counts should be considered when interpreting the magnitude of these findings. These results are scheduled to be presented at the Obesity Medicine Association 2026 annual conference to assist healthcare professionals in clinical decision-making.

Here is Why Novo Nordisk (NVO) is One of the Best Growth Stocks to Buy for the Next Decade

15 States with the Best Healthcare in the US

Novo Nordisk (NYSE: NVO) is a drug manufacturer for global pharmaceutical products that operates through two segments: Obesity & Diabetes Care and Rare Disease. The company was founded in 1923 and is headquartered in Denmark.

While we acknowledge the risk and potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.